Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.


TSX:WEED - Post by User

Comment by OptGreenon Feb 13, 2024 3:43pm
108 Views
Post# 35878295

RE:CanopyUSA

RE:CanopyUSA Things are just starting to move of late and most everything requires some sort of legal ability to operate, like licensing and legal status in place of operation. But they need to tighten up all aspects of the operation so far...big green potential on the med side, as the marketplace legalizes and the medical profession studies the plant and what it has to offer there could be much more to come from the plant as the info is gleanned and understood, much more effective product will become available over time.
There is plenty of positive to come from this plant on the med side and without the deadly side of many of the options??
Good to see canopy moving forward carefully from here....their assets and potential partners like Canopy/ USA offers going forward. Canopy is tied to some of the best in the business so they should be able to connect with many, if they choose? The assets they have or are in agreements with and are planning on acquiring going forward and add the ever improving menu of flower etc. They could be global but need to get their lineup right and when ready, start farming for others and pick up the tactics to wheel/ deal with on their own. The industry will be global and will require some adjustments for the first year or two, until the system is running like it should. The illegal system is not tenable as it is, htey will be making the majority of the changes early....Klein and team are set up with some solid assets now and they could make qhite a splash going forward.
If this SP keeps heading lower, one has to add?
Everybody needs to do their DD and buy, sell or hold accordingly. JMHO...Opt
<< Previous
Bullboard Posts
Next >>